Remdesivir News, Photos, Videos and Tweets

Scottish firm to trial T cells as possible COVID-19 treatment - Reuters

A Scottish biotechnology firm said on Tuesday it would start clinical trials on a possible T cell treatment for COVID-19, aimed at reducing the need for intensive care among hospitalised patients.

remdesivir - Reuters
10:42am PDT - June 30th, 2020

Here are the 4 biggest breakthroughs we've made in figuring out how to fight the coronavirus, from the surprise success of a cheap steroid to the failure of hydroxychloroquine

  • Since the novel coronavirus emerged in January, hundreds of clinical trials have launched to test potential treatment options. 
  • Most trials are still ongoing or have failed. But the few that have succeeded have given frontline doctors valuab…

    remdesivir - Business Insider
    7:59am PDT - June 30th, 2020

Gilead sets a price for its coronavirus treatment — Pfizer's newest digital health bet — Reopenings reversed

Hello, Welcome to Dispensed Daily, your daily dose of healthcare news from Business Insider. Are you new to the newsletter? You can sign up here to get this email in your inbox every day. States and cities are starting to pause or reverse their plans to reope…

remdesivir - Business Insider
5:49am PDT - June 30th, 2020

Factbox: Latest on the worldwide spread of the coronavirus - Reuters

California and Texas saw record spikes in new COVID-19 infections on Monday, and Los Angeles reported an "alarming" one-day surge in America's second-largest city that put it over 100,000 cases.

remdesivir - Reuters
11:28pm PDT - June 29th, 2020

Factbox: Latest on the worldwide spread of the coronavirus - Reuters India

California and Texas saw record spikes in new COVID-19 infections on Monday, and Los Angeles reported an "alarming" one-day surge in America's second-largest city that put it over 100,000 cases.

remdesivir - Reuters
11:10pm PDT - June 29th, 2020

What you need to know about the coronavirus right now - Reuters UK

What you need to know about the coronavirus right now  Reuters UK

remdesivir - Reuters
10:54pm PDT - June 29th, 2020

PRESS DIGEST- New York Times business news - June 30 - Reuters UK

The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

remdesivir - Reuters
10:45pm PDT - June 29th, 2020

PRESS DIGEST- New York Times business news - June 30 - Reuters India

The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

remdesivir - Reuters
10:45pm PDT - June 29th, 2020

Breakingviews - Gilead gives glimpse into feverish drug market - Reuters

(Reuters Breakingviews) - Medicine may be a science but drug pricing is definitely an art. That’s especially true of Gilead Sciences’ treatment for Covid-19, given the lack of alternative treatments for a pandemic. The $2,300 price of a course of remdesivir m…

remdesivir - Reuters
1:23pm PDT - June 29th, 2020

Gilead's coronavirus treatment remdesivir will cost $3,120 for patients with private insurance

COVID-19 treatment's price will depend on whether private insurers or government programs like Medicaid are paying.

remdesivir - CBS News
12:02pm PDT - June 29th, 2020

Here's how much Covid-19 drug remdesivir will cost

Remdesivir, Gilead's antiviral drug for treating coronavirus infection, will cost $2,340 per patient.

remdesivir - CNN
10:17am PDT - June 29th, 2020

Key Covid-19 drugs to be hit by customs checks at ports

India Business News: Import consignments of crucial raw materials stuck at ports and airports will impact production of key Covid-19 drugs, Remdesivir and Favipiravir, as

remdesivir - The Times of India
9:34am PDT - June 29th, 2020

COVID-19 drug remdesivir could cost $3,120 for some US patients

Remdesivir is the first antiviral medication to show effectiveness against the novel coronavirus in human clinical trials.

remdesivir - ABC News
7:06am PDT - June 29th, 2020

The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it's charging up to $520 a vial for remdesivir (GILD)

  • After months of anticipation, Gilead announced Monday the price of remdesivir, the first effective coronavirus treatment.
  • The California drugmaker will charge governments of developed countries, including the US, $2,340 for a five-day treatm…

    remdesivir - Business Insider
    6:29am PDT - June 29th, 2020

Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient - Reuters UK

Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 (1,901 pounds) for a five-day treatment in the United States and some other developed countries, it said on Monday, as it set the price for a single vial at $390.

remdesivir - Reuters
6:26am PDT - June 29th, 2020

Coronavirus updates: More states close bars, slow reopening plans; Gilead Sciences sets price for remdesivir treatments

California Gov. Gavin Newsom ordered some bars to close. Arizona and Washington slow down reopenings. Latest coronavirus news.

remdesivir - USA Today
4:51am PDT - June 29th, 2020

Gilead prices COVID-19 drug candidate remdesivir at $390/vial in U.S. - Reuters

Gilead Sciences Inc said on Monday it has priced its COVID-19 treatment candidate remdesivir at $390 per vial in the United States and other developed countries.

remdesivir - Reuters
4:20am PDT - June 29th, 2020

Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient

Gilead Sciences, remdesivir’s maker, said its price will depend on who is paying and how long a patient takes the drug

remdesivir - The Wall Street Journal
4:00am PDT - June 29th, 2020

Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance

Gilead Sciences, remdesivir’s maker, said its price will depend on who is paying and how long a patient takes the drug

remdesivir - The Wall Street Journal
4:00am PDT - June 29th, 2020

FACTBOX-What doctors have learned about fighting COVID-19 - Reuters

In the six months since an entirely new coronavirus began spreading around the world, doctors and hospitals have learned a lot about how to treat patients with COVID-19, the potentially deadly disease caused by the virus.

remdesivir - Reuters
11:57am PDT - June 28th, 2020

Factbox: What doctors have learned about fighting COVID-19 - Reuters India

In the six months since an entirely new coronavirus began spreading around the world, doctors and hospitals have learned a lot about how to treat patients with COVID-19, the potentially deadly disease caused by the virus.

remdesivir - Reuters
10:02pm PDT - June 27th, 2020

What doctors have learned about fighting COVID-19 - Reuters

In the six months since an entirely new coronavirus began spreading around the world, doctors and hospitals have learned a lot about how to treat patients with COVID-19, the potentially deadly disease caused by the virus.

remdesivir - Reuters
9:43pm PDT - June 27th, 2020

FACTBOX-What doctors have learned about fighting COVID-19 - Reuters

In the six months since an entirely new coronavirus began spreading around the world, doctors and hospitals have learned a lot about how to treat patients with COVID-19, the potentially deadly disease caused by the virus.

remdesivir - Reuters
9:29pm PDT - June 27th, 2020

Old Drugs Could Reveal a New Way to Attack the Coronavirus

Researchers found that SARS-CoV-2 hijacks tendrils that grow from infected cells and may ride them to infect others. But existing compounds might slow their roll.

remdesivir - Wired
4:00am PDT - June 27th, 2020

Factbox: Latest on the worldwide spread of the coronavirus - Reuters India

A World Health Organization-led coalition fighting the COVID-19 pandemic is asking government and private sector donors to help raise $31.3 billion in the next 12 months to develop and deliver tests, treatments and vaccines for the disease.

remdesivir - Reuters
7:10pm PDT - June 26th, 2020